JunHe‘s wide-ranging practice spans M&A, private equity and capital market aspects, as well as IP, regulatory compliance and dispute resolution. The firm recently strengthened its technology licensing transactions, working with leading biotechnology and multinational pharmaceutical clients. The team is jointly led by Xudong Tao, focusing on debt and equity financing. Co-heads James Zhu and Zoe Wang lead on patent litigation, prosecution and strategy, while Frank Zhou is reputed for M&A, joint venture and private equity deals. Gerry Zhao excels in IP, corporate, licensing and collaboration transactions matters. Ning Liu is noted for her expertise in investment and financing.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘JunHe's legal services team boasts extensive experience in the pharmaceutical industry.'
'Drawing on their deep expertise and extensive practical experience, they can quickly analyse core issues and provide diverse, practical, and feasible solutions to various client needs when negotiating multiple cooperation models.'
- 'Compared to other law firms, Jun He's team members boast diverse professional backgrounds and continuously recruit experienced industry talent.'
- 'In terms of diversity, they prioritise the integration of diverse professional and cultural backgrounds within their team.'
- 'Through collaborative efforts across domestic and international teams, they offer clients a wider range of cross-border services.’
‘JunHe's Hao Zhao provided high-quality legal services in the BD transaction. He engaged in in-depth discussions with his counterparts, was familiar with various problem-solving approaches, and, through discussions with both parties, creatively, efficiently, and practically resolved issues.'
Key clients
- ImmuneOnco Biopharmaceuticals
- Genor Biopharma Co., Ltd
- Biocytogen
- Jacobio Pharmaceuticals Co., Ltd.
- Shanghai Xiao Fang Pharmaceutical Co.,Ltd
- Grifols, SA - Spain
- Worg Pharmaceuticals
- Shanghai Enkai Cell Technology Co., Ltd.
- China Resources Pharmaceutical Commercial Group Co., Ltd
- Shanghai Bracco Sine Pharmaceutical Corp. Ltd.
Work highlights
Advised Grifols on the sale of a 20% Stake in SRAAS and a strategic alliance with Haier Group and PRC Consortium.
Advised ImmuneOnco Biopharmaceuticals (Shanghai) Inc. on ex-China license and collaboration agreement with Instil Bio, Inc.
Advised Genor Biopharma on global license agreement and stock purchase agreement with TRC 2004.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Gerry Zhao
Practice head
Xudong Tao; James Zhu; Zoe Wang; Frank Zhou; Ning Liu
Other key lawyers
Hao Zhao